A novel monoclonal antibody, L1A3, is directed to the functional site of the α(v) integrin subunit

Hybridoma

Volumn 15, Issue 4, 1996, Pages 279-280

  Deryugina, Elena I ^a   Strongin, Alex ^a   Yu, Caroline ^b   Bourdon, Mario A ^a  

^a La Jolla Institute for Experimental Medicine   (United States)

^b Cell Applications Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY L 1 A 3; UNCLASSIFIED DRUG; VITRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HYBRIDOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0029763060     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.279     Document Type: Article

References (33)

1. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
2. Schwartz MA: Signaling by integrins: Implications for tumorigenesis. Cancer Res 1993;51:1503-1505.
3. Sonnenberg A: Integrins and their ligands. Curr Top Microbiol Immunol 1993;184:7-35.
4. Ruoslahti E, and Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-478.
5. Houghton AN, Eisinger M, Albino AP, Cairncross JG, and Old LJ: Surface antigens of melanocytes and melanomas. J Exp Med 1982;156:1755-1766.
6. Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, and Old LJ: Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res 1985;45:4401-4411.
7. De Vries JE, Keizer GD, te Velde AA, Voordouw A, Ruiter D, Rümke P. Spits H, and Figdor CG: Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells. Int J Cancer 1986;38:465-473.
8. Rouslahti E, Hayman EG, Pierschbacher M, and Engvall E: Fibronectin: Purification, immunochemical properties, and biological activities. Methods Enzymol 1982;82:803-831.
9. 3 integrins. J Cell Sci 1993;105:1001-1012.
10. Kilian PL, Kaffka KL, Biondi DA, Lipman JM, Benjamin WR, Feldman D, and Campen CA: Antiproliferative effect of interleukin-1 on human ovarian carcinoma cell line (NIH:OVCAR-3). Cancer Res 1991;51:1823-1828.
11. Deryugina El, and Bourdon MA: Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 1996;109:643-652.
12. 6 in cell attachment to fibronectin. J Biol Chem 1994;269:6940-6948.
13. 8 cytoplasmic domain. J Biol Chem 1994;269:28708-28715.
14. Cheresh DA, and Spiro RC: Biosnthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem 1987;262:17703-17711.
15. Cheresh DA, Berliner SA, Vicente V, and Ruggeri Z: Recognition of distinct adhesive sites on fibrinogen by related integrin on platelets and endothelial cells. Cell 1989;58:945-953.
16. 1). J Biol Chem 1990;265:5934-5937.
17. 3 on human melanoma cells. Cancer Metastasis Rev 1991;10:3-10.
18. 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Biol Chem 1991;113:919-929.
19. Leavesley PI, Ferguson GD, Wayner EA, and Cheresh DA: Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 1992;117:1101-1107.
20. 3 rescues melanoma cells from apoptosis in a three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994;91:8856-8860.
21. 1. J Biol Chem 1995;270:26232-26238.
22. Sriramarao P, and Bourdon MA: Melanoma cell invasive and metastatic potential correlates with endothelial cell reorganization and tenascin expression. Endothelium 1996;4:85-97.
23. Basson CT, Kocher O, Basson MD, Asis A, and Madri JA: Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β1 correlates with reciprocal effects on cell migration. J Cell Physiol 1992;153:118-128.
24. Leavesley PI, Schwartz MA, Rosenfeld M, and Cheresh DA: Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993;121:163-170.
25. 5-directed cell motility but not adhesion on vitronectin. J Cell Biol 1994;127:859-866.
26. 3 involves a discrete cation-binding site that regulates conformation. J Biol Chem 1996;271:1364-1370.
27. Blood CH, and Zetter BR: Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1990;1032:89-118.
28. Felding-Habermann B, Mueller BM, Romerdahl CA, and Cheresh DA: Involvement of integrin α gene expression in human melanoma tumorigenicity. J Clin Invest 1992;89:2018-2022.
29. Weidner N, Carroll PR, Flax J, Blumenfeld W, and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
30. Weinstat-Saslow D, and Steeg PS: Angiogenesis and colonization in the tumor metastatic process: Basic and applied advances. FASEB J 1994;8:401-407.
31. 6 heterodimer in normal human keratinocytes: Implications for wound healing. J Cell Biol 1995;129:853-965.
32. 3 for angiogenesis. Science 1994;264:569-571.
33. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-1164.